In May 24, 2019, the Beijing IP Court recognized Cisco’s “CISCO in Chinese” mark on network communication equipment as well-known in China and revoked the decision held by the Trademark Review and Adjudication Board (TRAB).

At the beginning of March 2019, BEIJING EAST IP LTD received good news once again. In “2018 Patent Agency Rating Result Notification” issued by Beijing Patent Attorneys Association, BEIJING EAST IP LTD was reelected in the patent agency rating list. After continuous hard work of many years and by virtue of professional ability and careful service concept, BEIJING EAST IP LTD was awarded as AAAAA agency (BEIJING EAST IP LTD was awarded as AAA agency and AAAA agency respectively in the last two rating activities), which shows the overall ability of BEIJING EAST IP LTD in Intellectual Property service fields and reflects high recognition of governments and clients on our business level and service quality.

BEIJING EAST IP LTD and Tsinghua University have a long-term relationship. Dr. Lulin GAO, the founder of BEIJING EAST IP LTD, serves as a Visiting Professor and sets up scholarship in Tsinghua University School of Law. Dr. Lulin GAO has three children and all of them received higher education in Tsinghua University. After being founded in 2002, BEIJING EAST IP LTD recruited tens of employees who graduated from Tsinghua University, including Dr. Xiaodong LI, the General Manager of BEIJING EAST IP LTD.

Appointed Translators: Jason WANG / Austin CHANG, Beijing East IP Law Firm Author: Baoqing ZANG, Trademark Review and Adjudication Board (TRAB) Original Chinese text: China Industry and Commerce Newspaper June 21, 2016

On February 28, the Beijing IP Court (“IP Court”) issued a decision in Qilu Pharmaceutical v. the PRB ((2017)京73行初字No. 5365), which reversed a ruling by the Patent Reexamination Board (“PRB”) that upholds the validity of Patent No. 200910176994.1 (the “’994 patent”) owned by Beijing Sihuan Pharmaceutical (“Sihuan”). The IP Court holds that the inauthentic experimental data presented in the original description result in the failure to satisfy the enablement requirement.

China has three types of patents, i.e., invention, utility model, and design. The utility model patent does not have the counterpart in some other jurisdictions such as the USA, so some essential aspects of the utility model patent will be introduced below for better understanding of it.

On December 20, 2017, in the Patent Reexamination Board of SIPO (PRB) v. Beijing Winsunny Harmony Science & Technology Co., Ltd. ((2016)最高法行再41号), the Supreme Court held that a Markush claim, when drawn to a class of chemical compounds, should be interpreted as a set of Markush elements rather than a set of independent specific compounds. The present case is a petition for retrial filed by the PRB, requesting the Supreme Court to review the second-instance decision made by the Beijing High People’s Court (“High Court”). In reversing the PRB’s decision in the invalidation proceedings instituted by Beijing Winsunny Harmony Science & Technology Co., Ltd. (“Winsunny”), the High Court recognized a Markush claim as claiming a set of parallel technical solutions.